The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Acs:180 & Advia Centaur Afp Immunoassay.
Device ID | K020806 |
510k Number | K020806 |
Device Name: | ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY |
Classification | Kit, Test,alpha-fetoprotein For Testicular Cancer |
Applicant | BAYER CORP. 63 NORTH ST. Medfield, MA 02052 -1688 |
Contact | Thomas F Flynn |
Correspondent | Thomas F Flynn BAYER CORP. 63 NORTH ST. Medfield, MA 02052 -1688 |
Product Code | LOJ |
CFR Regulation Number | 866.6010 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-03-12 |
Decision Date | 2002-03-27 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414598376 | K020806 | 000 |
00630414598369 | K020806 | 000 |
00630414294117 | K020806 | 000 |